Incannex announces intention to redomicile to united states, list all shares on nasdaq

Highlights: incannex to redomicile to the united states via a scheme of arrangement pursuant to australian law a newly formed delaware corporation (incannex healthcare inc.) will become the ultimate parent company of the group, following implementation of the scheme of arrangement the shares of common stock issued by incannex healthcare inc. in exchange for all outstanding ordinary shares of incannex, pursuant to the scheme of arrangement, will be listed on nasdaq incannex will have greater access to capital market more cognisant of ihl's value proposition with peer comparison companies trading at significantly higher market valuations the incannex board also anticipates: improved access to large pools of lower cost equity capital over the long term increased alignment with prominent pharmaceutical companies a simplified corporate structure for any future potential merger or acquisition transactions enhanced access to fda resources incannex shareholders and optionholders will be given the opportunity to vote on redomiciling to the us in october 2023; if approved, the change in nature of the shares in incannex can be implemented rapidly. if approved, incannex will assist shareholders to seamlessly transfer their holdings to us shares tradable on australia broking platforms to ensure little to no disruption to shareholders.
IXHL Ratings Summary
IXHL Quant Ranking